PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with Merck

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice